A 66-year-old woman with a hypervascular pancreatic mass

Jun-Ho Choi

doi:10.5946/ce.2023.057

Articles

Page Path: HOME > Clin Endosc > Volume 56(6); 2023 > Article

CME for
KSGE members

Boost Your Learning with Quiz A 66-year-old woman with a hypervascular pancreatic mass: Jun-Ho Choi^,; Clinical Endoscopy 2023;56(6):827-828.
DOI: https://doi.org/10.5946/ce.2023.057
Published online: May 18, 2023

Department of Internal Medicine, Dankook University College of Medicine, Cheonan, Korea

Correspondence: Jun-Ho Choi Department of Internal Medicine, Dankook University College of Medicine, 119 Dandae-ro, Dongnam-gu, Cheonan 31116, Korea E-mail: cjh@dankook.ac.kr

• Received: February 19, 2023 • Revised: February 23, 2023 • Accepted: February 24, 2023

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

1,799 Views
103 Download

Full Article

Download PDF

Quiz
Answer
NOTES
REFERENCES

Quiz

A 66-year-old woman with no previous medical history experienced early satiety and nonspecific epigastric pain for six months before visiting a local hospital. Computed tomography revealed a 2-cm solid mass with contrast enhancement in the pancreatic body (Fig. 1A). The patient was transferred to the pancreatic center of our institution for further evaluation. On presentation, the physical examination was unremarkable. Laboratory tests, which included pancreatic enzymes and tumor markers, were within the normal ranges.

Subsequent magnetic resonance imaging revealed a hypervascular mass in the pancreatic body (Fig. 1B). Endoscopic ultrasound (EUS) examination revealed a homogeneous, hypoechoic 2.0×1.8 cm mass (Fig. 2A), which exhibited strong enhancement on contrast-enhanced EUS (Fig. 2B, 12 seconds after injecting SonoVue, Bracco Inc.). EUS-guided fine-needle biopsy (FNB) was performed using a 22-gauge histology needle. However, the FNB specimens were insufficient for histopathological diagnosis.

What is the most likely diagnosis in this case?

Answer

Laparoscopic distal pancreatectomy was performed because the mass was presumed to be a neuroendocrine tumor (NET), given its imaging characteristics and size. The patient recovered well postoperatively. Pathological examination of the specimen revealed a solid lesion, measuring 2-cm on its greater axis (Fig. 3A). Microscopically, the mass comprised cells with a clear cytoplasm, no signs of atypia, and no mitosis. The cells were arranged in tubular/acinar structures without lumina (Fig. 3B). Histology of the tumor was consistent with the diagnosis of a solid-type serous cystic neoplasm (SCN) (Fig. 3C).

While the most common histotype of SCN is the microcystic honeycomb pattern, these lesions can also, albeit rarely, appear solid due to the enhancement of the intracystic septa and closely opposed walls.¹ Solid-appearing SCNs are benign tumors that typically occur in elderly women. Most solid-appearing SCNs have shown arterial hyperenhancement on imaging studies and can often be mistaken for other solid-enhancing pancreatic masses, such as NETs, solid pseudopapillary neoplasms, intrapancreatic accessory spleen, and metastatic renal cancer.²^,³ It is challenging to provide a definitive diagnosis of this lesion prior to surgery.⁴

This case of solid-appearing SCN adds to our knowledge and experience in diagnosing and treating hypervascular masses in the pancreas.

Conflicts of Interest

Jun-Ho Choi is currently serving as a KSGE Publication Committee member in Clinical Endoscopy; however, he was not involved in the peer reviewer selection, evaluation, or decision process of this article.

Funding

None.

Fig. 1.

Cross-sectional imaging of the pancreatic mass. (A) On computed tomography, the pancreatic mass showed increased contrast enhancement in the arterial phase (arrows). (B) The arterial phase on magnetic resonance imaging revealed the hypervascularity of the mass in the pancreatic body (arrows).

Fig. 2.

Endoscopic ultrasound. (A) B-mode endoscopic ultrasound revealed a well-defined, hypoechoic mass in the pancreatic body (arrowheads). (B) Contrast-enhanced harmonic imaging showing hyperenhancement inside the tumor.

Fig. 3.

Histopathological findings. (A) A photograph of a gross specimen of the mass revealed a round, well-defined, and solid mass measuring 20 mm in size. (B) Low magnification of the microphotograph revealed that the tumor was composed of numerous microcysts with densely fibrocollagenous stroma (hematoxylin and eosin stain, ×40). (C) Higher magnification of the microphotograph (hematoxylin-eosin stain, ×200) showing a single layer of bland-looking cuboidal epithelium resting on the fibrous cyst wall (hematoxylin and eosin stain, ×200).

REFERENCES

1. Wcislak SM, Stiles ZE, Deneve JL, et al. Hypervascular lesions of the pancreas: Think before you act. Am J Surg 2019;218:362–367.Article PubMed
2. Kalb B, Sarmiento JM, Kooby DA, Adsay NV, Martin DR. MR imaging of cystic lesions of the pancreas. Radiographics 2009;29:1749–1765.Article PubMed
3. Park HS, Kim SY, Hong SM, et al. Hypervascular solid-appearing serous cystic neoplasms of the pancreas: differential diagnosis with neuroendocrine tumours. Eur Radiol 2016;26:1348–1358.Article PubMed PDF
4. Nakamura S, Murata Y, Uchida K, et al. Microcystic serous cystadenoma mimicking pancreatic neuroendocrine neoplasm: report of a resected case with preoperative diagnostic difficulty and review of the literature. Surg Case Rep 2022;8:188.Article PubMed PMC PDF

Figure & Data

REFERENCES

Citations

Citations to this article as recorded by

PubReader
ePub Link

Cite

CITE: export Copy Download Format; Close

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

RIS — For EndNote, ProCite, RefWorks, and most other reference management software
BibTeX — For JabRef, BibDesk, and other BibTeX-specific software

Include:

Citation for the content below
Citation and abstract for the content below

A 66-year-old woman with a hypervascular pancreatic mass

Clin Endosc. 2023;56(6):827-828. Published online May 18, 2023

DOI: https://doi.org/10.5946/ce.2023.057

XML Download

Figure

A 66-year-old woman with a hypervascular pancreatic mass

Fig. 1. Cross-sectional imaging of the pancreatic mass. (A) On computed tomography, the pancreatic mass showed increased contrast enhancement in the arterial phase (arrows). (B) The arterial phase on magnetic resonance imaging revealed the hypervascularity of the mass in the pancreatic body (arrows).

Fig. 2. Endoscopic ultrasound. (A) B-mode endoscopic ultrasound revealed a well-defined, hypoechoic mass in the pancreatic body (arrowheads). (B) Contrast-enhanced harmonic imaging showing hyperenhancement inside the tumor.

Fig. 3. Histopathological findings. (A) A photograph of a gross specimen of the mass revealed a round, well-defined, and solid mass measuring 20 mm in size. (B) Low magnification of the microphotograph revealed that the tumor was composed of numerous microcysts with densely fibrocollagenous stroma (hematoxylin and eosin stain, ×40). (C) Higher magnification of the microphotograph (hematoxylin-eosin stain, ×200) showing a single layer of bland-looking cuboidal epithelium resting on the fibrous cyst wall (hematoxylin and eosin stain, ×200).

Fig. 1.

Fig. 2.

Fig. 3.

A 66-year-old woman with a hypervascular pancreatic mass